Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-006564
Filing Date
2024-11-14
Accepted
2024-11-14 12:03:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 ASTRIA THERAPEUTICS, INC. p24-3215sc13g.htm SC 13G 60720
2 JOINT ACQUISITION STATEMENT p24-3215exhibit99_1.htm EX-99.1 4580
  Complete submission text file 0000902664-24-006564.txt   66988
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Subject) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88910 | Film No.: 241459146
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 632 BROADWAY SUITE 602 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 602 NEW YORK NY 10012 6469894000
Vestal Point Capital, LP (Filed by) CIK: 0001974915 (see all company filings)

EIN.: 922296021 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G